Your browser is no longer supported. Please, upgrade your browser.
Settings
NSTG NanoString Technologies, Inc. daily Stock Chart
NSTG [NASD]
NanoString Technologies, Inc.
Index- P/E- EPS (ttm)-1.59 Insider Own0.80% Shs Outstand37.73M Perf Week-2.35%
Market Cap1.33B Forward P/E- EPS next Y-1.94 Insider Trans-46.79% Shs Float37.45M Perf Month-2.25%
Income-57.40M PEG- EPS next Q-0.52 Inst Own- Short Float9.21% Perf Quarter14.11%
Sales124.50M P/S10.71 EPS this Y57.60% Inst Trans-11.23% Short Ratio7.29 Perf Half Y18.44%
Book/sh3.65 P/B9.66 EPS next Y22.10% ROA-21.30% Target Price35.50 Perf Year37.20%
Cash/sh7.10 P/C4.97 EPS next 5Y- ROE-57.70% 52W Range13.85 - 38.40 Perf YTD26.74%
Dividend- P/FCF- EPS past 5Y15.90% ROI-18.50% 52W High-8.18% Beta1.34
Dividend %- Quick Ratio8.30 Sales past 5Y21.40% Gross Margin62.80% 52W Low154.58% ATR1.95
Employees551 Current Ratio8.90 Sales Q/Q-4.00% Oper. Margin-38.70% RSI (14)49.38 Volatility5.11% 5.36%
OptionableYes Debt/Eq1.22 EPS Q/Q-50.50% Profit Margin-46.10% Rel Volume0.64 Prev Close36.04
ShortableYes LT Debt/Eq1.22 EarningsAug 10 AMC Payout- Avg Volume473.22K Price35.26
Recom1.80 SMA20-1.80% SMA504.67% SMA20020.81% Volume303,249 Change-2.16%
Nov-15-19Initiated Stifel Buy
Oct-09-18Initiated UBS Buy
Oct-12-17Downgrade Janney Buy → Neutral
Apr-20-17Downgrade Morgan Stanley Overweight → Equal-Weight
Dec-11-13Upgrade Robert W. Baird Neutral → Outperform $12 → $18
Aug-07-20 08:46AM  
Aug-06-20 06:00AM  
06:00AM  
Aug-05-20 05:49PM  
Aug-03-20 12:31PM  
06:00AM  
Jul-08-20 06:00AM  
Jul-02-20 08:39AM  
Jun-23-20 11:06AM  
Jun-17-20 05:05PM  
Jun-16-20 05:41PM  
May-20-20 09:00AM  
May-19-20 09:37AM  
May-14-20 04:00PM  
May-12-20 06:00AM  
May-11-20 06:00AM  
May-09-20 12:01PM  
May-07-20 06:35PM  
04:01PM  
Apr-15-20 09:00AM  
Apr-07-20 06:34AM  
Apr-06-20 04:01PM  
Mar-27-20 09:47AM  
Mar-07-20 07:05AM  
Mar-05-20 06:00AM  
Mar-04-20 07:21AM  
Mar-03-20 09:41AM  
Mar-02-20 06:05AM  
Feb-28-20 09:44AM  
Feb-26-20 04:00PM  
Feb-20-20 06:00AM  
Feb-19-20 12:31PM  
Feb-18-20 06:00AM  
Feb-10-20 09:00AM  
Feb-06-20 08:00AM  
Jan-20-20 09:40AM  
Jan-15-20 01:28PM  
Jan-12-20 06:00PM  
Jan-02-20 04:01PM  
Dec-11-19 06:00AM  
Dec-10-19 02:25PM  
Dec-06-19 12:59PM  
Dec-03-19 06:05PM  
05:09PM  
05:00PM  
06:00AM  
Nov-25-19 04:01PM  
04:01PM  
Nov-20-19 05:29PM  
Nov-13-19 04:01PM  
Nov-07-19 04:01PM  
Nov-04-19 06:15PM  
04:01PM  
06:00AM  
06:00AM  
Oct-31-19 06:00AM  
Oct-28-19 02:57PM  
10:32AM  
Oct-21-19 02:03PM  
Oct-07-19 04:05PM  
Oct-04-19 04:30PM  
Oct-02-19 06:00AM  
Sep-24-19 08:00AM  
Sep-23-19 06:00AM  
Sep-06-19 07:15AM  
Aug-28-19 06:00AM  
Aug-21-19 11:57PM  
Aug-19-19 06:00AM  
Aug-15-19 01:15AM  
Aug-08-19 07:16PM  
Aug-06-19 06:00AM  
Aug-01-19 10:53AM  
03:23AM  
Jul-31-19 06:55PM  
04:01PM  
Jul-30-19 09:29AM  
Jul-28-19 01:53AM  
Jul-24-19 10:32AM  
Jul-23-19 03:20PM  
07:13AM  
Jul-22-19 04:01PM  
Jul-18-19 03:55PM  
Jul-15-19 06:00AM  
Jul-12-19 03:32PM  
Jul-10-19 06:00AM  
Jun-20-19 03:30PM  
Jun-18-19 04:01PM  
Jun-17-19 09:24AM  
Jun-12-19 11:59AM  
01:29AM  
Jun-11-19 11:24PM  
May-30-19 04:01PM  
May-26-19 06:35AM  
May-15-19 06:00AM  
May-10-19 11:50AM  
09:23AM  
May-09-19 08:58PM  
05:55PM  
04:44PM  
04:01PM  
NanoString Technologies, Inc. provides life science tools for translational research and molecular diagnostic products worldwide. The company offers nCounter Analysis System, an automated, multi-application, digital detection, and counting system. It provides nCounter MAX and FLEX systems that include Prep Station, an automated liquid handling component that processes and prepares samples for data collection; and nCounter Digital Analyzer, which collects data from samples by taking images of the immobilized fluorescent reporters in the sample cartridge and processing the data into output files. The company also offers nCounter SPRINT Profiler, an instrument that provides liquid handling steps and the digital analysis through use of a microfluidic cartridge; and nSolver Analysis Software, a data analysis program that enables researchers to check, normalize, and analyze their data. In addition, it provides custom CodeSets; and pan cancer and 360 gene expression, CAR-T characterization, neuropathology and neuro-inflammation gene expression, autoimmune disease gene expression, miRNA expression, human organ transplant, human and mouse metabolic pathway, and human and mouse fibrosis panels. Further, the company offers nCounter based reagents that allow users to design customized assays; Master Kits, such as ancillary reagents and plasticware to setup and process samples in the nCounter Prep Station and nCounter Digital Analyzer; and Prosigna molecular diagnostic test kits. The company is also developing GeoMx DSP system to enable the field of spatial genomics; and Hyb & Seq molecular profiling system to determine and analyze gene sequences within biological samples. It has collaboration with Celgene Corporation; Merck & Co., Inc.; Medivation, Inc.; and Astellas Pharma, Inc. NanoString Technologies, Inc. was founded in 2003 and is headquartered in Seattle, Washington.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
HERSHBERG ROBERTDirectorJul 15Option Exercise11.201,50016,8003,390Jul 17 04:53 PM
HERSHBERG ROBERTDirectorJul 15Sale36.151,50054,2241,890Jul 17 04:53 PM
GRAY R BRADLEYPresident and CEOJul 06Option Exercise1.9240,00076,800142,903Jul 08 04:34 PM
GRAY R BRADLEYPresident and CEOJul 06Sale37.0340,0001,481,200102,903Jul 08 04:34 PM
Bailey K ThomasChief Financial OfficerJun 30Sale29.173,26095,1050Jul 02 04:35 PM
GRAY R BRADLEYPresident and CEOJun 19Option Exercise1.9213,63726,183116,540Jun 22 04:13 PM
GRAY R BRADLEYPresident and CEOJun 19Sale33.5813,637457,930102,903Jun 22 04:13 PM
GRAY R BRADLEYPresident and CEOJun 18Option Exercise1.926,36312,217109,266Jun 22 04:13 PM
GRAY R BRADLEYPresident and CEOJun 18Sale33.576,363213,606102,903Jun 22 04:13 PM
HERSHBERG ROBERTDirectorJun 15Option Exercise11.201,50016,8003,390Jun 17 07:45 PM
HERSHBERG ROBERTDirectorJun 15Sale30.791,50046,1861,890Jun 17 07:45 PM
BROWN J. CHADSVP, Sales & MarketingJun 01Option Exercise20.4512,635258,35134,879Jun 03 04:18 PM
BROWN J. CHADSVP, Sales & MarketingJun 01Sale30.8334,7121,070,133167Jun 03 04:18 PM
Bailey K ThomasChief Financial OfficerMay 18Option Exercise8.165,93748,4469,197May 20 04:16 PM
Bailey K ThomasChief Financial OfficerMay 18Sale31.865,937189,1303,260May 20 04:16 PM
HERSHBERG ROBERTDirectorMay 15Option Exercise7.4710,16875,95510,168May 18 06:13 PM
HERSHBERG ROBERTDirectorMay 15Sale30.8310,168313,4340May 18 06:13 PM
WAITE CHARLES P JRDirectorMay 14Option Exercise8.451,73414,6521,734May 18 06:13 PM
WAITE CHARLES P JRDirectorMay 14Sale30.171,73452,3150May 18 06:13 PM
WAITE CHARLES P JRDirectorMay 12Option Exercise8.456,09451,4946,094May 14 04:13 PM
WAITE CHARLES P JRDirectorMay 12Sale32.276,094196,6530May 14 04:13 PM
Malloy KirkDirectorApr 20Option Exercise16.361,50024,5401,500Apr 22 04:27 PM
Malloy KirkDirectorApr 20Sale30.001,50045,0000Apr 22 04:27 PM
Malloy KirkDirectorApr 15Option Exercise7.471,0007,4701,000Apr 17 04:12 PM
Malloy KirkDirectorApr 15Sale25.611,00025,6130Apr 17 04:12 PM
GRAY R BRADLEYPresident and CEOMar 16Option Exercise0.0021,9940111,558Mar 18 05:22 PM
GHESQUIERE DAVID W.SVP, Corporate & Business DevMar 16Option Exercise0.003,177071,577Mar 18 05:21 PM
Bailey K ThomasChief Financial OfficerMar 16Option Exercise0.005,37605,376Mar 18 05:21 PM
BROWN J. CHADSVP, Sales & MarketingMar 16Option Exercise0.005,376023,554Mar 18 05:22 PM
BEECHEM JOSEPH MSVP, Research & DevelopmentMar 16Option Exercise0.005,376057,982Mar 18 05:21 PM
Bailey K ThomasChief Financial OfficerMar 10Option Exercise8.167,91764,6037,917Mar 11 04:17 PM
Bailey K ThomasChief Financial OfficerMar 10Sale31.477,917249,1850Mar 11 04:17 PM
GRAY R BRADLEYPresident and CEOMar 09Option Exercise2.0942,04987,79098,673Mar 11 04:18 PM
GRAY R BRADLEYPresident and CEOMar 09Sale31.6242,0491,329,48056,624Mar 11 04:18 PM
GHESQUIERE DAVID W.SVP, Corporate & Business DevFeb 27Option Exercise12.5022,000275,00076,169Mar 02 04:05 PM
GHESQUIERE DAVID W.SVP, Corporate & Business DevFeb 27Sale35.0922,000771,99354,169Mar 02 04:05 PM
BROWN J. CHADSVP, Sales & MarketingFeb 18Option Exercise14.981,45821,84211,713Feb 18 05:18 PM
BROWN J. CHADSVP, Sales & MarketingFeb 18Sale33.511,45848,85810,255Feb 18 05:18 PM
GRAY R BRADLEYPresident and CEOFeb 14Option Exercise2.2420,00044,80070,050Feb 18 05:19 PM
BROWN J. CHADSVP, Sales & MarketingFeb 14Option Exercise12.286,10274,90916,357Feb 18 05:18 PM
BROWN J. CHADSVP, Sales & MarketingFeb 14Sale32.006,102195,26410,255Feb 18 05:18 PM
GRAY R BRADLEYPresident and CEOFeb 14Sale33.6320,000672,56450,050Feb 18 05:19 PM
BROWN J. CHADSVP, Sales & MarketingFeb 13Option Exercise16.358,801143,89619,056Feb 13 04:47 PM
Malloy KirkDirectorFeb 12Option Exercise12.802,50032,0101,500Feb 13 04:46 PM
Malloy KirkDirectorFeb 12Sale31.182,50077,9500Feb 13 04:46 PM
GRAY R BRADLEYPresident and CEOFeb 11Option Exercise2.2420,00044,80070,050Feb 13 04:47 PM
BROWN J. CHADSVP, Sales & MarketingFeb 11Option Exercise16.357,700125,89517,955Feb 13 04:47 PM
GRAY R BRADLEYPresident and CEOFeb 11Sale31.8720,000637,36850,050Feb 13 04:47 PM
BROWN J. CHADSVP, Sales & MarketingFeb 11Sale32.0016,501528,03210,255Feb 13 04:47 PM
Bailey K ThomasChief Financial OfficerFeb 03Sale28.1025,872727,0760Feb 05 04:15 PM
GRAY R BRADLEYPresident and CEOJan 21Option Exercise2.2420,00044,80070,050Jan 23 04:10 PM
GRAY R BRADLEYPresident and CEOJan 21Sale29.9920,000599,80450,050Jan 23 04:10 PM
Bailey K ThomasChief Financial OfficerJan 16Option Exercise0.0035,000035,000Jan 21 04:53 PM
GHESQUIERE DAVID W.SVP, Corporate & Business DevJan 10Option Exercise12.5019,279240,98873,448Jan 13 05:47 PM
GHESQUIERE DAVID W.SVP, Corporate & Business DevJan 10Sale29.0719,279560,43754,169Jan 13 05:47 PM
GHESQUIERE DAVID W.SVP, Corporate & Business DevJan 09Option Exercise12.503003,75054,469Jan 13 05:47 PM
GHESQUIERE DAVID W.SVP, Corporate & Business DevJan 09Sale29.023008,70754,169Jan 13 05:47 PM
Malloy KirkDirectorDec 13Option Exercise7.471,0007,4701,000Dec 13 05:48 PM
Malloy KirkDirectorDec 13Sale25.591,00025,5940Dec 13 05:48 PM
YOUNG WILLIAMDirectorNov 22Option Exercise2.2424,12554,04054,125Nov 25 04:24 PM
YOUNG WILLIAMDirectorNov 22Sale24.8624,125599,83730,000Nov 25 04:24 PM
BROWN J. CHADSVP, Sales & MarketingNov 19Option Exercise6.802,18814,87814,159Nov 19 05:06 PM
BROWN J. CHADSVP, Sales & MarketingNov 19Sale24.003,90493,69810,255Nov 19 05:06 PM
BROWN J. CHADSVP, Sales & MarketingNov 18Option Exercise16.3515,784258,06836,294Nov 19 05:06 PM
BROWN J. CHADSVP, Sales & MarketingNov 18Sale23.8027,524655,02410,255Nov 19 05:06 PM
BROWN J. CHADSVP, Sales & MarketingNov 15Option Exercise1.4818,91628,05726,329Nov 19 05:06 PM
Bailey K ThomasChief Financial OfficerNov 12Option Exercise8.165,93748,4465,937Nov 13 04:42 PM
Bailey K ThomasChief Financial OfficerNov 12Sale23.005,937136,5540Nov 13 04:42 PM
GHESQUIERE DAVID W.SVP, Corporate & Business DevNov 11Option Exercise0.002,500054,786Nov 13 04:34 PM
Malloy KirkDirectorOct 15Option Exercise7.471,0007,4701,000Oct 17 04:13 PM
Malloy KirkDirectorOct 15Sale22.001,00022,0000Oct 17 04:13 PM
WAITE CHARLES P JRDirectorSep 13Sale21.751,70737,1300Sep 13 05:54 PM
YOUNG WILLIAMDirectorAug 22Option Exercise2.2424,12554,04054,125Aug 26 04:10 PM
YOUNG WILLIAMDirectorAug 22Sale25.2924,125610,06030,000Aug 26 04:10 PM
GHESQUIERE DAVID W.SVP, Corporate & Business DevAug 19Option Exercise19.3618,421356,63370,243Aug 21 04:35 PM
GHESQUIERE DAVID W.SVP, Corporate & Business DevAug 19Sale28.2318,421520,11351,822Aug 21 04:35 PM
Malloy KirkDirectorAug 13Option Exercise0.001,00001,000Aug 14 04:35 PM
Malloy KirkDirectorAug 13Sale25.051,00025,0510Aug 14 04:35 PM
GRAY R BRADLEYPresident and CEOAug 12Option Exercise2.2440,00089,60089,905Aug 14 04:35 PM
GRAY R BRADLEYPresident and CEOAug 12Sale24.8440,000993,70649,905Aug 14 04:35 PM